We are live on ! Find out more
ONCS

OncoSec Medical Incorporated

Delisted

ONCS was delisted on the 23rd of June, 2023.

30 hedge funds and large institutions have $1.86M invested in OncoSec Medical Incorporated in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% less funds holding

Funds holding: 3330 (-3)

30% less capital invested

Capital invested by funds: $2.64M → $1.86M (-$787K)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

56% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 9

Holders
30
Holders Change
-3
Holders Change %
-9.09%
% of All Funds
0.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
9
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$1K -$1.78K -13 -57%
WAP
27
Wealthcare Advisory Partners
Pennsylvania
$1K
Wells Fargo
28
Wells Fargo
California
$1K
AFM
29
Anson Funds Management
Texas
-$412K -2,925 Closed
Point72 Asset Management
30
Point72 Asset Management
Connecticut
-$295K -2,094 Closed
Millennium Management
31
Millennium Management
New York
-$26K -182 Closed
Citadel Advisors
32
Citadel Advisors
Florida
-$22K -155 Closed
TSS
33
Two Sigma Securities
New York
-$10K -69 Closed
Invesco
34
Invesco
Georgia
-$8K -60 Closed

ONCS Hedge Fund Activity: Q1 2019 in Review

30 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q1 2019, worth a combined $1.86M — down 30% from $2.64M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ONCS and 3 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 4 added.

The largest buyer was Intrinsic Edge Capital Management, opening a new position worth an estimated $313K. The largest seller was Anson Funds Management, exiting entirely with an estimated $412K sold.

  • 30 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q1 2019, down from 33 in Q4 2018.
  • Funds reported $1.86M of OncoSec Medical Incorporated stock for Q1 2019, down 30% quarter-over-quarter.
  • 3 funds opened new OncoSec Medical Incorporated positions in Q1 2019 and 6 closed out, a net change of -3 holders.
  • The largest OncoSec Medical Incorporated buyer in Q1 2019 was Intrinsic Edge Capital Management, an estimated $313K added.
  • The largest OncoSec Medical Incorporated seller in Q1 2019 was Anson Funds Management, an estimated $412K sold.

Based on aggregated 13F filings for Q1 2019.